The future of technology of clinical trials.
Change is never easy, especially in a conservative and highly regulated industry like healthcare. The last decade has seen major transformation across every aspect of our life due to the advancement of digital technologies and yet the pharmaceutical industry has traditionally been slow to adapt and embrace this new paradigm.
COVID-19 has transformed the pharmaceutical supply chain and there has been a significant re-thinking and re-engineering of the clinical trial process. As we come out on the other side of the pandemic, we have proved that we can adapt to new ways of working and remain reliable and professional. So, let’s take more chances.
Register for this webinar to hear how digital technology is transforming the drug development process and appraise a number of emerging mechanisms which are continuing to drive additional flexibility in the management and optimization of clinical trials globally.
Topics
• The new norm
• The ongoing evolution
• What does the future hold?
Webinar breakdown
• The new norm
o Where we have come from and what is new now after covid
• The ongoing evolution
o What is new that is on the cusp of delivery – already out there and being experimented
• What does the future hold?
o What else could we be doing? Embracing?
Presented by
Brian Keesee,
Vice President & General Manager, Global Clinical Operations & Supply
Brian Keesee, Vice President & General Manager of PCI’s Global Clinical Operations & Supply, has spent his entire career in the Pharmaceutical industry.
In his current role, Brian is responsible for Global Clinical Operations and Project Management for PCI Clinical Trial Services sites globally.
Prior to his role at PCI, he held leadership positions in Compliance, Operations Management, and Project Management within the pharma industry.
Brian has managed large global clinical studies and offers extensive experience and expertise in Supply Chain Management, Logistics, Clinical Package and Label design, Project Management, Cold Chain Technologies and IRT.
Brian brings a unique perspective based on his global project management knowledge from his prior positions within the Clinical Supplies Industry, his Compliance and Operations roles at AmerisourceBergen Drug Corporation, and his involvement in a Lean Six Sigma Black Belt Program.
He holds a Bachelor of Science in Business Administration from Missouri Western State University.
Morgan Brandt,
Digital Product Director,
Morgan Brandt is the Global Director of Digital Products for PCI Pharma Services. She has extensive knowledge and experience in the digital space and has previously worked for Capital One, DuPont and AmerisourceBergen. Morgan completed her MBA in Marketing with honors from Saint Joseph’s University.
Tim Roberts ,
Vice President – Global Sales, Clinical Services
Tim brings over 22 years of experience in clinical packaging. He has been successfully leading and building PCI’s Global Clinical & Manufacturing Sales Team for the last three years, and before this led its UK Clinical Operations. He has made a significant and positive impact on team members, Clinical business results and most importantly PCI’s client base. Prior to joining PCI, Tim delivered strong results within similar healthcare solution providers focused on sales, program management and operations leadership roles.
